Type 2 diabetes mellitus

Cites (414)

Items 201–400 of 414

1. Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype
   Hawa, Mohammed I., Kolb, Hubert, Schloot, Nanette, Beyan, Huriya, Paschou, Stavroula A., Buzzetti, Raffaella, Mauricio, Didac, De Leiva, Alberto, Yderstraede, Knud, Beck-Neilsen, Henning et al. · 2013 · Diabetes Care
2. Sulfonylurea Induced β-Cell Apoptosis in Cultured Human Islets
   Kathrin Maedler, Richard David Carr, Domenico Bosco, Richard A. Zuellig, Thierry Berney, Marc Yves Donath · 2005 · The Journal of Clinical Endocrinology & Metabolism
3. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy
   P. James B. Dyck, Jane E. Norell, P. James B. Dyck · 1999 · Neurology
4. Alpha-glucosidase inhibitors for type 2 diabetes mellitus
   Van de Laar, Floris A, Lucassen, Peter LBJ, Akkermans, Reinier P, Van de Lisdonk, Eloy H, Rutten, Guy EHM, Van Weel, Chris · 2005 · Cochrane Database of Systematic Reviews
5. Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
   Ralph Anthony DeFronzo, Roy Eldor, Muhammad A Abdul‐Ghani · 2013 · Diabetes Care
6. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
   Richter, Bernd, Bandeira-Echtler, Elizabeth, Bergerhoff, Karla, Lerch, Christian · 2008 · Cochrane Database of Systematic Reviews
7. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents
   Petersen, Kitt F, Dufour, Sylvie, Shulman, Gerald I · 2005 · PLoS Medicine
8. Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics
   Baron, Alain D, Schaeffer, Linda, Shragg, Paul, Kolterman, Orville G · 1987 · Diabetes
9. Type 2 Diabetes Mellitus and Hypertension
   Lastra, Guido, Syed, Sofia, Kurukulasuriya, L. Romayne, Manrique, Camila, Sowers, James R. · 2014 · Endocrinology and Metabolism Clinics of North America
10. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes
    Sho‐ichi Yamagishi · 2010 · Experimental Gerontology
11. Metformin: A review of its metabolic effects
    Kenneth J. Cusi, Ralph Anthony DeFronzo · 1998 · Diabetes reviews
12. The disposal of an oral glucose load in patients with non-insulin-dependent diabetes
    Ferrannini, Eleuterio, Simonson, Donald C., Katz, Lee D., Reichard, George, Bevilacqua, Stefano, Barrett, Eugene J., Olsson, Maggie, DeFronzo, Ralph A. · 1988 · Metabolism
13. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance
    Kawamori, Ryuzo, Tajima, Naoko, Iwamoto, Yasuhiko, Kashiwagi, Atsunori, Shimamoto, Kazuaki, Kaku, Kohei · 2009 · The Lancet
14. The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
    Dick de Zeeuw, Blai Coll, Dennis L. Andress, John J. Brennan, Hui Jun Tang, Mark T. Houser, Ricardo Correa‐Rotter, Donald E. Kohan, Hiddo J.L. Heerspink, Hirofumi Makino et al. · 2014 · Journal of the American Society of Nephrology
15. Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes
    Anders H. Rosengren, Ramūnas Jokubka, Damon Tojjar, Charlotte Granhall, Ola Hansson, Daiqing Li, Vini Nagaraj, Thomas M. Reinbothe, Jonatan Tuncel, Lena Eliasson et al. · 2009 · Science
16. Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus
    Christianne L. Roumie, Adriana M. Hung, Robert A. Greevy, Carlos Gabriel Grijalva, Xulei Liu, Harvey J. Murff, Tom A. Elasy, Marie R. Griffin · 2012 · Annals of Internal Medicine
17. Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
    Ralph A. DeFronzo, Andrew J. Lewin, Sanjay Dhanji Patel, Dacheng Liu, Renee Kaste, Hans Juergen Woerle, Uli C. Broedl · 2015 · Diabetes Care
18. Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange
    Ralph Anthony DeFronzo, Eleuterio Ferrannini, Rosa Hendler, John Wahren, Philip Felig · 1978 · Proceedings of the National Academy of Sciences
19. Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes
    DeFronzo, Ralph A., Hompesch, Marcus, Kasichayanula, Sreeneeranj, Liu, Xiaoni, Hong, Ying, Pfister, Marc, Morrow, Linda A., Leslie, Bruce R., Boulton, David W., Ching, Agatha et al. · 2013 · Diabetes Care
20. Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
    Tao, Hanlin, Zhang, Yong, Zeng, Xiangang, Shulman, Gerald I, Jin, Shengkan · 2014 · Nature Medicine
21. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents
    Gulli, Giovanni, Ferrannini, Eleuterio, Stern, Michael, Haffner, Steven, DeFronzo, Ralph A · 1992 · Diabetes
22. The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions.
    M. Bensellam, D. Laybutt, J. Jonas · 2012 · Molecular and Cellular Endocrinology
23. The regulatory subunits of PI3K, p85α and p85β, interact with XBP-1 and increase its nuclear translocation
    Sang Won Park, Yingjiang Zhou, Justin Lee, Allen Lu, Cheng Sun, Jason Chung, Kohjiro Ueki, Umut Özcan · 2010 · Nature Medicine
24. Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
    Jens Juul Holst, Filip Krag Knop, Tina Vilsbøll, Thure Krarup, Sten Madsbad · 2011 · Diabetes Care
25. Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives
    Toshio Ogihara, Hiromi Rakugi, H IKEGAMI, Hiroshi Mikami, Kazuko Masuo · 1995 · American Journal of Hypertension
26. Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
    Drucker, Daniel J. · 2013 · Diabetes
27. Dissection of the insulin signaling pathway via quantitative phosphoproteomics
    Marcus Krüger, Irina Kratchmarova, Blagoy Blagoev, Yu‐Hua Tseng, C. Ronald Kahn, Matthias Mann · 2008 · Proceedings of the National Academy of Sciences
28. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer
    Jae Myoung Suh, Johan W. Jonker, Maryam Ahmadian, Regina M. Goetz, Denise E. Lackey, Olivia Osborn, Zhifeng Huang, Weilin Liu, Eiji Yoshihara, Theo H. van Dijk et al. · 2014 · Nature
29. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement
    LeFevre, Michael L., on behalf of the U.S. Preventive Services Task Force* · 2014 · Annals of Internal Medicine
30. The DREAM trial – Authors' reply
    Gerstein, Hertzel C, Yusuf, Salim, Bosch, Jackie · 2006 · The Lancet
31. Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
    Vanita R. Aroda, Robert R. Henry, Jenny Han, Wenying Huang, Mary Beth DeYoung, Tamara Darsow, Byron J. Hoogwerf · 2012 · Clinical Therapeutics
32. Effects of Pyridoxamine in Combined Phase 2 Studies of Patients with Type 1 and Type 2 Diabetes and Overt Nephropathy
    Mark E. Williams, Warren Kline Bolton, Raja G. Khalifah, Thorsten P. Degenhardt, Robert J. Schotzinger, Janet B. McGill · 2007 · American Journal of Nephrology
33. Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30–50% of Filtered Glucose Load in Humans
    Muhammad A Abdul‐Ghani, Ralph Anthony DeFronzo, Luke Norton · 2013 · Diabetes
34. Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT
    Kahn, Steven E., Lachin, John M., Zinman, Bernard, Haffner, Steven M., Aftring, R. Paul, Paul, Gitanjali, Kravitz, Barbara G., Herman, William H., Viberti, Giancarlo, Holman, Rury R. et al. · 2011 · Diabetes
35. Functional Analysis of Tumor Necrosis Factor (TNF) Receptors in TNF-α-Mediated Insulin Resistance in Genetic Obesity**This work is supported in part by a grant from the NIH (DK-52539).
    K. Teoman Uysal, Sarah M. Wiesbrock, Gökhan S. Hotamışlıgil · 1998 · Endocrinology
36. Preservation of β-Cell Function: The Key to Diabetes Prevention
    DeFronzo, Ralph A., Abdul-Ghani, Muhammad A. · 2011 · The Journal of Clinical Endocrinology & Metabolism
37. TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
    Burant, Charles F, Viswanathan, Prabhakar, Marcinak, John, Cao, Charlie, Vakilynejad, Majid, Xie, Benhuai, Leifke, Eckhard · 2012 · The Lancet
38. The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients
    Bogdan Balas, Muhammad Rais Baig, Catherine E. Watson, Beth E. Dunning, Monica Ligueros‐Saylan, Yibin Wang, Yanling He, Celia Darland, Jens Juul Holst, Carolyn Fiona Deacon et al. · 2007 · The Journal of Clinical Endocrinology & Metabolism
39. Outpatient Management of Uncomplicated Lower-Extremity Infections in Diabetic Patients
    Benjamin Alan Lipsky · 1990 · Archives of Internal Medicine
40. Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes
    Bunck, Mathijs C., Cornér, Anja, Eliasson, Bjorn, Heine, Robert J., Shaginian, Rimma M., Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Diamant, Michaela · 2011 · Diabetes Care
41. Successful Treatment of Neuropathies in Patients With Diabetes Mellitus
    David A. Krendel, Donal A. Costigan, Linton C. Hopkins · 1995 · Archives of Neurology
42. Influence of miRNA in insulin signaling pathway and insulin resistance: micro‐molecules with a major role in type‐2 diabetes
    Chiranjib Chakraborty, C. George Priya Doss, Sanghamitra Bandyopadhyay, Govindasamy Agoramoorthy · 2014 · Wiley Interdisciplinary Reviews - RNA
43. Internet interventions to support lifestyle modification for diabetes management: A systematic review of the evidence
    Cotter, Alexander P., Durant, Nefertiti, Agne, April A., Cherrington, Andrea L. · 2014 · Journal of Diabetes and its Complications
44. Dose-Response Relation Between Sulfonylurea Drugs and Mortality in Type 2 Diabetes Mellitus: A Population-Based Cohort Study
    Simpson, S. H. · 2006 · Canadian Medical Association Journal
45. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): A double-blind randomised controlled study
    Zinman, Bernard, Harris, Stewart B, Neuman, Jan, Gerstein, Hertzel C, Retnakaran, Ravi R, Raboud, Janet, Qi, Ying, Hanley, Anthony JG · 2010 · The Lancet
46. A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
    Marzena Wójcik, Izabela Burzyńska-Pędziwiatr, Lucyna A. Woźniak · 2010 · Current Medicinal Chemistry
47. The Diabetic Foot
    Andrew J.M. Boulton · 1988 · Medical Clinics of North America
48. Reversal of Hypertriglyceridemia, Fatty Liver Disease, and Insulin Resistance by a Liver-Targeted Mitochondrial Uncoupler
    Rachel J. Perry, Tae-Han Kim, Xian‐Man Zhang, Hui‐Young Lee, Dominik Hans Pesta, Violeta Popov, Dongyan Zhang, Yasmeen Rahimi, Michael J. Jurczak, Gary W. Cline et al. · 2013 · Cell Metabolism
49. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes
    Mariana Igoillo‐Esteve, Lorella Marselli, Daniel Andrade Cunha, Laurence Ladrière, Fernanda Ortis, F. A. Grieco, Francesco Dotta, Gordon C. Weir, Piero Marchetti, Decio Laks Eizirik et al. · 2010 · Diabetologia
50. β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
    Philippe A. Halban, Kenneth S. Polonsky, Donald W. Bowden, Meredith A. Hawkins, Charlotte Ling, Kieren J. Mather, Alvin C. Powers, Christopher J. Rhodes, Lori Sussel, Gordon C. Weir · 2014 · The Journal of Clinical Endocrinology & Metabolism
51. Mortality risk among sulfonylureas: a systematic review and network meta-analysis
    Scot H. Simpson, Jayson Lee, Sabina Choi, Ben Vandermeer, Ahmed S Abdelmoneim, Travis R Featherstone · 2014 · The Lancet Diabetes & Endocrinology
52. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection
    Andrew Gough, Mary Clapperton, Nancy Rolando, Alethea VM Foster, John Philpott‐Howard, MICHAEL E. EDMONDS · 1997 · The Lancet
53. Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release
    Garvey, W. Timothy, Ryan, Donna H., Henry, Robert, Bohannon, Nancy J.V., Toplak, Hermann, Schwiers, Michael, Troupin, Barbara, Day, Wesley W. · 2014 · Diabetes Care
54. Autonomic Neuropathy and Painless Myocardial Infarction in Diabetic Patients: Histologic Evidence of Their Relationship
    Isaac Faerman, E. Faccio, José Milei, R.Alcala Nuñez, Mauricio N. Jadzinsky, Dora Fox, Mauricio Rapaport · 1977 · Diabetes
55. Lipotoxicity disrupts incretin-regulated human β cell connectivity
    Hodson, David J., Mitchell, Ryan K., Bellomo, Elisa A., Sun, Gao, Vinet, Laurent, Meda, Paolo, Li, Daliang, Li, Wen-Hong, Bugliani, Marco, Marchetti, Piero et al. · 2013 · Journal of Clinical Investigation
56. The Endoplasmic Reticulum Chaperone Improves Insulin Resistance in Type 2 Diabetes
    Kentaro Ozawa, Mayuki Miyazaki, Munehide Matsuhisa, Katsura Takano, Yoshihisa Nakatani, Masahiro Hatazaki, Takashi Tamatani, Kazuya Yamagata, Jun-ichiro Miyagawa, Yasuko Kitao et al. · 2005 · Diabetes
57. Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the <scp>E</scp> fficacy and <scp>D</scp> urability of <scp>I</scp> nitial <scp>C</scp> ombination <scp>T</scp> herapy for <scp>T</scp> ype 2 <scp>D</scp> iabetes ( <scp>EDICT</scp> ): a randomized trial
    Abdul‐Ghani, M. A., Puckett, C., Triplitt, C., Maggs, D., Adams, J., Cersosimo, E., DeFronzo, R. A · 2015 · Diabetes, Obesity and Metabolism
58. Insulin Resistance Alters Islet Morphology in Nondiabetic Humans
    Teresa Mezza, Giovanna Muscogiuri, Gian Pio Sorice, Gennaro Clemente, Jiang Hu, Alfredo Pontecorvi, Jens Juul Holst, Andrea Giaccari, Rohit Kulkarni · 2013 · Diabetes
59. The effect of rate of weight loss on long-term weight management: a randomised controlled trial
    Purcell, Katrina, Sumithran, Priya, Prendergast, Luke A, Bouniu, Celestine J, Delbridge, Elizabeth, Proietto, Joseph · 2014 · The Lancet Diabetes &amp; Endocrinology
60. Thiazolidinediones improve β-cell function in type 2 diabetic patients
    Gastaldelli, Amalia, Ferrannini, Ele, Miyazaki, Yoshinori, Matsuda, Masafumi, Mari, Andrea, DeFronzo, Ralph A. · 2007 · American Journal of Physiology-Endocrinology and Metabolism
61. Effects of Electrical Stimulation on Wound Healing in Patients With Diabetic Ulcers
    Lucinda L. Baker, Richard B. Chambers, Sharon K. DeMuth, Fernando Villar · 1997 · Diabetes Care
62. Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies
    Adria Giacca, Changting Xiao, Andrei I. Oprescu, André C. Carpentier, Gary F. Lewis · 2010 · American Journal of Physiology-Endocrinology and Metabolism
63. Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets
    Robert A. Ritzel, Juris Jendrik Meier, Chia‐Yu Lin, Johannes D. Veldhuis, Peter C. Butler · 2006 · Diabetes
64. A Prospective Study of Weight Training and Risk of Type 2 Diabetes Mellitus in Men
    Anders Grøntved, Eric B. Rimm, Walter Churchill Willett, Lars Bo Andersen, Frank B. Hu · 2012 · Archives of Internal Medicine
65. Current Advances and Travails in Islet Transplantation
    David M. Harlan, Norma Sue Kenyon, Olle Korsgren, Bart O. Roep, for the Immunology of Diabetes Society · 2009 · Diabetes
66. Targeting inflammation in diabetes: Newer therapeutic options
    Neeraj Kumar Agrawal · 2014 · World Journal of Diabetes
67. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes
    Fangfang Song, Wenbo Jia, Ying Yao, Yafei Hu, Lin Lei, Jie Ming Lin, Xiufa Sun, Liegang Liu · 2007 · Clinical Science
68. Secondary Failure of Metformin Monotherapy in Clinical Practice
    Jonathan Betz Brown, Christopher Conner, Gregory A. Nichols · 2009 · Diabetes Care
69. Pathophysiology of prediabetes
    Ferrannini, Ele, Gastaldelli, Amalia, Iozzo, Patricia · 2011 · Medical Clinics of North America
70. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes
    Varman T. Samuel, Sara A. Beddow, Takanori Iwasaki, Xian‐Man Zhang, Xin Chu, Christopher D. Still, Glenn S. Gerhard, Gerald I. Shulman · 2009 · Proceedings of the National Academy of Sciences
71. The Stunned β Cell: A Brief History
    Ferrannini, Ele · 2010 · Cell Metabolism
72. Influence of Obesity, Impaired Glucose Tolerance, and NIDDM on LDL Structure and Composition: Possible Link Between Hyperinsulinemia and Atherosclerosis
    Hisham A. Barakat, John W. Carpenter, Virginia D. McLendon, Prabhaker G. Khazanie, Nancy Leggett-Frazier, Judith Heath, Richard H.L. Marks · 1990 · Diabetes
73. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study
    Jeffrey S. Dungan · 2011 · Yearbook of Obstetrics Gynecology and Women s Health
74. Incidence of Diabetes Mellitus by Clinical Type
    L. Joseph Melton, Pasquale J Palumbo, Chu-Pin Chu · 1983 · Diabetes Care
75. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature
    Eugene J. Barrett, Hong Wang, Charles T. Upchurch, Zhenqi Liu · 2011 · American Journal of Physiology-Endocrinology and Metabolism
76. The Effect of Previous Coronary-Artery Bypass Surgery on the Prognosis of Patients with Diabetes Who Have Acute Myocardial Infarction
    Detre, Katherine M., Lombardero, Manuel S., Brooks, Maria Mori, Hardison, Regina M., Holubkov, Richard, Sopko, George, Frye, Robert L., Chaitman, Bernard R. · 2000 · New England Journal of Medicine
77. Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes
    Wang, Chih‐Hao, Wang, Ching‐Chu, Huang, Hsin‐Chang, Wei, Yau‐Huei · 2013 · The FEBS Journal
78. Familial Risks for Type 2 Diabetes in Sweden
    Kari Hemminki, Xinjun Li, Kristina Sundquist, Jan Sundquist · 2009 · Diabetes Care
79. AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
    Aaron Wong, Jacqueline Howie, John R. Petrie, Chim Choy Lang · 2009 · Clinical Science
80. Supplementation of Vitamin C Reduces Blood Glucose and Improves Glycosylated Hemoglobin in Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study
    G. Dakhale, Harshal V. Chaudhari, M. Shrivastava · 2011 · Advances in Pharmacological Sciences
81. Intracellular Lipid Accumulation in Liver and Muscle and the Insulin Resistance Syndrome
    Cristina Lara‐Castro, William Timothy Garvey · 2008 · Endocrinology and Metabolism Clinics of North America
82. GAD Antibodies in NIDDM: Ten-year follow-up from the diagnosis
    LEO K. NISKANEN, Tiinamaija Tuomi, Jukka Karjalainen, Leif Groop, Matti I.J. Uusitupa · 1995 · Diabetes Care
83. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance
    Jennifer L. Cantley, Toru Yoshimura, João Paulo Camporez, Dongyan Zhang, François R. Jornayvaz, Naoki Kumashiro, Fitsum Guebre‐Egziabher, Michael J. Jurczak, Mario Kahn, Blas A. Guigni et al. · 2013 · Proceedings of the National Academy of Sciences
84. Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
    on behalf of the Scottish Diabetes Research Network Epidemiology Group and the Diabetes and Cancer Research Consortium, Levin, Daniel, Bell, Samira, Sund, Reijo, Hartikainen, Sirpa A., Tuomilehto, Jaakko, Pukkala, Eero, Keskimäki, Ilmo, Badrick, Ellena, Renehan, Andrew G. et al. · 2015 · Diabetologia
85. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
    Antonio Cervera, Estela Wajcberg, Apiradee Sriwijitkamol, Marianella Fernandez, Pengou Zuo, Curtis L. Triplitt, Nicolas Musi, Ralph A. DeFronzo, Eugênio Cersósimo · 2008 · American Journal of Physiology-Endocrinology and Metabolism
86. Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance
    Naoki Kumashiro, Sara A. Beddow, Daniel F. Vatner, Sachin K. Majumdar, Jennifer L. Cantley, Fitsum Guebre‐Egziabher, Ioana Fat, Blas A. Guigni, Michael J. Jurczak, Andreas L. Birkenfeld et al. · 2013 · Diabetes
87. Defective innervation of heart in diabetic autonomic neuropathy.
    R H Lloyd‐Mostyn, Peter Watkins · 1975 · BMJ
88. Personalized Management of Hyperglycemia in Type 2 Diabetes
    Itamar Raz, Matthew C. Riddle, Julio Rosenstock, John B. Buse, Silvio E. Inzucchi, Philip Home, Stefano Del Prato, Ele Ferrannini, Juliana C.N. Chan, Lawrence A. Leiter et al. · 2013 · Diabetes Care
89. PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
    Olivier Bézy, Thien Thuan Tran, Jussi Pihlajamäki, Ryo Suzuki, Brice Emanuelli, Jonathan Winnay, Marcelo A. Mori, Joel T. Haas, Sudha B. Biddinger, Michael Leitges et al. · 2011 · Journal of Clinical Investigation
90. The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications
    Madsbad, S. · 2014 · Diabetes, Obesity and Metabolism
91. A Multivariate Logistic Regression Equation to Screen for Diabetes
    Bahman P. Tabaei, William H. Herman · 2002 · Diabetes Care
92. The artificial pancreas: current status and future prospects in the management of diabetes
    Peyser, Thomas, Dassau, Eyal, Breton, Marc, Skyler, Jay S. · 2014 · Annals of the New York Academy of Sciences
93. Clinical features and treatment of maturity onset diabetes of the young (MODY)
    Daphne Su-Lyn Gardner, E Shyong Tai · 2012 · Diabetes Metabolic Syndrome and Obesity
94. SOCS proteins causing trouble in insulin action
    P. Lebrun, Emmanuel VAN OBBERGHEN · 2007 · Acta Physiologica
95. β-Cell function in type 2 diabetes
    Ele Ferrannini, Andrea Mari · 2014 · Metabolism
96. The pharmacology of sulfonylureas
    Thomas G. Skillman, Jerome M. Feldman · 1981 · The American Journal of Medicine
97. Cardiac Denervation in Diabetic Neuropathy
    Peter Watkins, JONATHAN D. MACKAY · 1980 · Annals of Internal Medicine
98. Are we overestimating the loss of beta cells in type 2 diabetes?
    Marselli, Lorella, Suleiman, Mara, Masini, Matilde, Campani, Daniela, Bugliani, Marco, Syed, Farooq, Martino, Luisa, Focosi, Daniele, Scatena, Fabrizio, Olimpico, Francesco et al. · 2014 · Diabetologia
99. The target of metformin in type 2 diabetes
    Ferrannini, Ele · 2014 · New England Journal of Medicine
100. Troglitazone Decreases the Proportion of Small, Dense LDL and Increases the Resistance of LDL to Oxidation in Obese Subjects
     Cees J. Tack, Paul Smits, Pierre N.M. Demacker · 1998 · Diabetes Care
101. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
     Esteve, Eduardo, Ricart, Wifredo, Fernández-Real, Jose-Manuel · 2011 · Current Opinion in Clinical Nutrition and Metabolic Care
102. Mitochondrial signals drive insulin secretion in the pancreatic β-cell
     Wiederkehr, Andreas, Wollheim, Claes B. · 2012 · Molecular and Cellular Endocrinology
103. Reversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathway
     Barak Blum, Adam N Roose, Ornella Barrandon, René Maehr, Anthony C. Arvanites, Lance S. Davidow, Jeffrey C. Davis, Quinn P. Peterson, Lee L. Rubin, Douglas A. Melton · 2014 · eLife
104. Rosiglitazone Improves Downstream Insulin Receptor Signaling in Type 2 Diabetic Patients
     Yoshinori Miyazaki, Helen He, Lawrence J. Mandarino, Ralph Anthony DeFronzo · 2003 · Diabetes
105. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy
     Aidan McElduff, N. Wah Cheung, David H. McIntyre, Janet Lagstrom, Barry N J Walters, Jeremy J. N. Oats, Peter Wein, Glynis P. Ross, David S Simmons · 2005 · The Medical Journal of Australia
106. In Vivo Actions of Peroxisome Proliferator–Activated Receptors
     Roy Eldor, Ralph A. DeFronzo, Muhammad A Abdul‐Ghani · 2013 · Diabetes Care
107. CLUSTERING OF HEART DISEASE RISK FACTORS IN DIABETIC COMPARED TO NONDIABETIC ADULTS
     Deborah L. Wingard, Elizabeth L. Barrett-Connor, Michael H. Criqui, Lucina Suarez · 1983 · American Journal of Epidemiology
108. The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta‐analysis
     Josefine E. Schopman, Airin C.R. Simon, Sanne Johanna Maria Hoefnagel, Joost B.L. Hoekstra, Rob J. P. M. Scholten, Frits Holleman · 2013 · Diabetes/Metabolism Research and Reviews
109. Insights Into the Molecular Mechanism for Type 2 Diabetes Susceptibility at the <i>KCNQ1</i> Locus From Temporal Changes in Imprinting Status in Human Islets
     Travers, Mary E., Mackay, Deborah J.G., Dekker Nitert, Marloes, Morris, Andrew P., Lindgren, Cecilia M., Berry, Andrew, Johnson, Paul R., Hanley, Neil, Groop, Leif C., McCarthy, Mark I. et al. · 2013 · Diabetes
110. Protein Tyrosine Phosphatase 1B Inhibitors: A Molecular Level Legitimate Approach for the Management of Diabetes Mellitus
     Suresh Thareja, Saurabh Aggarwal, Tulika Bhardwaj, Manoj Kumar · 2010 · Medicinal Research Reviews
111. The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach
     Paolo Pozzilli, Richard David Leslie, Juliana C.N. Chan, R De Fronzo, L. Monnier, Itamar Raz, Stefano Del Prato · 2010 · Diabetes/Metabolism Research and Reviews
112. A Role for Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) in the Regulation of Hepatic Gluconeogenesis
     Romana Stark, Fitsum Guebre‐Egziabher, Xiaojian Zhao, Colleen N. Feriod, Jianying Dong, Tiago C. Alves, Simona Ioja, Rebecca LePine Pongratz, Sanjay Bhanot, Michael Roden et al. · 2014 · Journal of Biological Chemistry
113. Myeloid Cell-Restricted Insulin Receptor Deficiency Protects Against Obesity-Induced Inflammation and Systemic Insulin Resistance
     Jan Mauer, Bhagirath Chaurasia, Leona Plum, Thomas Quast, Brigitte Hampel, Matthias Blüher, Waldemar Kolanus, C. Ronald Kahn, Jens C. Brüning · 2010 · PLoS Genetics
114. Prevention of Diabetes With Pioglitazone in ACT NOW
     DeFronzo, Ralph A., Tripathy, Devjit, Schwenke, Dawn C., Banerji, MaryAnn, Bray, George A., Buchanan, Thomas A., Clement, Stephen C., Gastaldelli, Amalia, Henry, Robert R., Kitabchi, Abbas E. et al. · 2013 · Diabetes
115. Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy
     E. Niakan · 1986 · Archives of Internal Medicine
116. Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients
     Jersey Chen, Thomas A. Marciniak, Martha J. Radford · 1999 · Journal of the American College of Cardiology
117. Glucokinase Activators for Diabetes Therapy
     Franz M. Matschinsky, Bogumił Zelent, Nicolai M. Doliba, Changhong Li, Jane M. Vanderkooi, Ali Naji, Ramakanth Sarabu, Joseph S. Grimsby · 2011 · Diabetes Care
118. Long-Term Effects of Bariatric Surgery on Meal Disposal and β-Cell Function in Diabetic and Nondiabetic Patients
     Stefania Camastra, Elza Muscelli, Amalia Gastaldelli, Jens Juul Holst, Brenno Astiarraga, Simona Baldi, Monica Nannipieri, Demetrio Ciociaro, Marco Anselmino, Andrea Mari et al. · 2013 · Diabetes
119. The syndrome of diabetic amyotrophy
     Sudhansu Chokroverty, Marc G. Reyes, F. A. Rubino · 1977 · Annals of Neurology
120. Imeglimin increases glucose‐dependent insulin secretion and improves β‐cell function in patients with type 2 diabetes
     Giovanni Pacini, Andrea Mari, Pascale Fouqueray, Sébastien Bolze, Michael Roden · 2015 · Diabetes Obesity and Metabolism
121. Short-Term Intensive Therapy in Newly Diagnosed Type 2 Diabetes Partially Restores Both Insulin Sensitivity and β-Cell Function in Subjects With Long-Term Remission
     Yun Hu, Lirong Li, Yu Xu, Tingting Yu, Guoyu Tong, Hong Huang, Yan Bi, Jianping Weng, Dalong Zhu · 2011 · Diabetes Care
122. Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts
     Motté, Evi, Szepessy, Edit, Suenens, Krista, Stangé, Geert, Bomans, Myriam, Jacobs-Tulleneers-Thevissen, Daniel, Ling, Zhidong, Kroon, Evert, Pipeleers, Daniel, Beta Cell Therapy Consortium EU-FP7 · 2014 · American Journal of Physiology-Endocrinology and Metabolism
123. Assessment of intracellular insulin content during all steps of human islet isolation procedure
     Heide Brandhorst · 1998 · Cell Transplantation
124. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy
     Lindsay Harrison, BEVERLEY A. ADAMS-HUET, Philip Raskin, Ildiko Lingvay · 2012 · Diabetes Care
125. Dipeptidyl peptidase‐4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta‐analysis of randomized controlled trials
     Katherine Esposito, D. Cozzolino, Giuseppe Bellastella, Maria Ida Maiorino, Paolo Chiodini, Antonio Ceriello, Dario Giugliano · 2011 · Diabetes Obesity and Metabolism
126. Serum Antioxidant Concentrations and Metabolic Syndrome Are Associated among U.S. Adolescents in Recent National Surveys
     May A. Beydoun, Jose A. Canas, Hind A. Beydoun, Xiaoli Chen, Monal R. Shroff, Alan B. Zonderman · 2012 · Journal of Nutrition
127. β-Cell Function, Incretin Effect, and Incretin Hormones in Obese Youth Along the Span of Glucose Tolerance From Normal to Prediabetes to Type 2 Diabetes
     Sara Fleet Michaliszyn, Andrea Mari, SoJung Lee, Fida F Bacha, Hala Mounir Tfayli, Lama O. Farchoukh, Ele Ferrannini, Silva A Arslanian · 2014 · Diabetes
128. On ceramides, other sphingolipids and impaired glucose homeostasis
     Philip Just Larsen, Norbert Tennagels · 2014 · Molecular Metabolism
129. Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study
     Roy Eldor, Ehud Arbit, Asher Corcos, Miriam Kidron · 2013 · PLoS ONE
130. Pregnancy and diabetes
     David R. McCance · 2011 · Best Practice & Research Clinical Endocrinology & Metabolism
131. Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1
     Kazuyuki Hiratani, Tetsuro Haruta, Akihiro Tani, Junko Kawahara, Isao Usui, Masashi Kobayashi · 2005 · Biochemical and Biophysical Research Communications
132. Endoplasmic Reticulum Stress: Another Link Between Obesity and Insulin Resistance/Inflammation?
     Guenther H. Boden · 2009 · Diabetes
133. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy
     Mahendra Prasad Bhatt, Y.-C. Lim, Kwon‐Soo Ha · 2014 · Cardiovascular Research
134. DGAT1 inhibitors as anti-obesity and anti-diabetic agents.
     Alan M. Birch, Linda K. Buckett, Andrew V. Turnbull · 2010 · PubMed
135. Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals
     Masafumi Matsuda, Ralph Anthony DeFronzo, Leonard C. Glass, Agostino Consoli, Mauro Giordano, Peter Bressler, Stefano DelPrato · 2002 · Metabolism
136. Afrezza Inhaled Insulin
     David Charles Klonoff · 2014 · Journal of Diabetes Science and Technology
137. Novel agents for the treatment of type 2 diabetes
     DeFronzo, Ralph A., Triplitt, Curtis L., Abdul-Ghani, Muhammad, Cersosimo, Eugenio · 2014 · Diabetes Spectrum
138. Protein Kinase C-ζ Activation Markedly Enhances β-Cell Proliferation
     Rupangi C. Vasavada, Lin Wang, Yuichi Fujinaka, Karen K. Takane, Taylor C. Rosa, José Manuel Mellado‐Gil, Peter A. Friedman, Adolfo Garcı́a-Ocaña · 2007 · Diabetes
139. Valuing Quality of Life and Improvements in Glycemic Control in People With Type 2 Diabetes
     Marcia A. Testa, Donald C. Simonson, Ralph R. Turner · 1998 · Diabetes Care
140. Diabetic proximal neuropathy
     Sub H. Subramony, Asa J. Wilbourn · 1982 · Journal of the Neurological Sciences
141. Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study
     on behalf of the RISC Investigators, Ferrannini, E., Natali, A., Muscelli, E., Nilsson, P. M., Golay, A., Laakso, M., Beck-Nielsen, H., Mari, A. · 2011 · Diabetologia
142. Can a Selective PPARγ Modulator Improve Glycemic Control in Patients With Type 2 Diabetes With Fewer Side Effects Compared With Pioglitazone?
     Alex M. DePaoli, Linda Slanec Higgins, Robert R. Henry, Christos Socrates Mantzoros, Fredrick L. Dunn · 2014 · Diabetes Care
143. Association of Dietary Vitamin C and E Intake and Antioxidant Enzymes in Type 2 Diabetes Mellitus Patients
     Zahra Rafighi, Atena Shiva, Shahin Arab, Rokia mohd yusof · 2013 · Global Journal of Health Science
144. Insulin‐Induced Microvascular Recruitment in Skin and Muscle are Related and Both are Associated with Whole‐Body Glucose Uptake
     Rick I. Meijer, Michiel P. de Boer, Martine R. Groen, Etto C. Eringa, Stephen Rattigan, Eugene J. Barrett, Yvo Michiel Smulders, Erik H. Serné · 2012 · Microcirculation
145. Role of Pyruvate Dehydrogenase Kinase 4 in Regulation of Blood Glucose Levels
     Nam Ho Jeoung, Robert A. Harris · 2010 · Korean Diabetes Journal
146. Regulation of Mitochondrial Biogenesis by Lipoprotein Lipase in Muscle of Insulin-Resistant Offspring of Parents With Type 2 Diabetes
     Katsutaro Morino, Kitt Falk Petersen, Saki Sono, Cheol Soo Choi, Varman T. Samuel, Aiping Lin, Amy E. Gallo, Hongyu Zhao, Atsunori Kashiwagi, Ira J. Goldberg et al. · 2012 · Diabetes
147. Patient‐reported outcomes following treatment with the human GLP‐1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes
     Bruce W. Bode, Marcia A. Testa, MELISSA L. MAGWIRE, Paula M. Hale, Mette Hammer, Lawrence Blonde, Alan J. Garber, on behalf of the LEAD‐3 Study Group · 2010 · Diabetes Obesity and Metabolism
148. Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist
     Yunzhao Tang, Annika S. Axelsson, Peter Spégel, Lotta E. Andersson, Hindrik Mulder, Leif Groop, Erik Renström, Anders H. Rosengren · 2014 · Science Translational Medicine
149. Feasibility of Insulin-Glucose Infusion in Diabetic Patients With Acute Myocardial Infarction: A report from the multicenter trial: DIGAMI
     Klas Malmberg, Suad Efendić, Lars Rydén · 1994 · Diabetes Care
150. Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients
     Ingrid M. Jazet, Gert Schaart, Amalia Gastaldelli, Eleuterio Ferrannini, Matthijs K. C. Hesselink, Patrick Schrauwen, Johannes Anthonius Romijn, J. Antonie Maassen, Hanno Pijl, D. Margriet Ouwens et al. · 2007 · Diabetologia
151. A Systems Biology Approach Identifies Inflammatory Abnormalities Between Mouse Strains Prior to Development of Metabolic Disease
     Marcelo A. Mori, Manway Liu, Olivier Bézy, Katrine Almind, Hagit Shapiro, Simon Kasif, C. Ronald Kahn · 2010 · Diabetes
152. Growth factor control of pancreatic islet regeneration and function
     Anke Aßmann, Charlotte Hinault, Rohit Kulkarni · 2008 · Pediatric Diabetes
153. CUTANEOUS MANIFESTATIONS OF DIABETES MELLITUS
     Nicholas G. Paron, Phillip W. Lambert · 2000 · Primary Care Clinics in Office Practice
154. Preconception care of women with diabetes: a review of current guideline recommendations
     Maimunah Mahmud, Danielle Mazza · 2010 · BMC Women s Health
155. Alpha-glucosidase inhibitors for type 2 diabetes mellitus (Review)
     Floris A Van de Laar, Peter LBJ Lucassen, Reinier Akkermans, Eloy H. van de Lisdonk, Guy E.H.M. Rutten, Chris van Weel · 2005 · Cochrane Database of Systematic Reviews
156. Effect of Vitamin C Supplementation on Postprandial Oxidative Stress and Lipid Profile in Type 2 Diabetic Patients
     Zohreh Mazloom, Najmeh Hejazi, Mohammad Hossein Dabbaghmanesh, Hamid-Reza Tabatabaei, Afsane Ahmadi, Hastimansooreh Ansar · 2011 · Pakistan Journal of Biological Sciences
157. Assessment of Intracellular Insulin Content during All Steps of Human Islet Isolation Procedure
     Heide Brandhorst, Daniel Brandhorst, Mathias D. Brendel · 1998 · Cell Transplantation
158. Observational follow‐up of the PROactive study: a 6‐year update
     Erland Erdmann, E. Song, Robert G. Spanheimer, A.-R. van Troostenburg de Bruyn, Alfonso Pérez · 2013 · Diabetes Obesity and Metabolism
159. Extranuclear Localization of SIRT1 and PGC-1α: An Insight into Possible Roles in Diseases Associated with Mitochondrial Dysfunction
     Katia Aquilano, Sara Baldelli, Beatrice Pagliei, Maria Rosa Ciriolo · 2012 · Current Molecular Medicine
160. Insulin response during the oral glucose tolerance test: The role of age, sex, body fat and the pattern of fat distribution
     Denis C. Muller, Dariush Elahi, J. D. Tobin, R Andres · 1996 · Aging Clinical and Experimental Research
161. Diabetic Amyotrophy: Current Concepts
     Howard W. Sander, Sudhansu Chokroverty · 1996 · Seminars in Neurology
162. Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases
     Jerry R. Colca, Steven P. Tanis, William G McDonald, Rolf F. Kletzien · 2013 · Expert Opinion on Investigational Drugs
163. Renal Hemodynamics in Recent-Onset Type II Diabetes
     Rainer Nowack, Elke Raum, Werner Friedrich Blum · 1992 · American Journal of Kidney Diseases
164. Clinical Evaluation of a Semipermeable Polymeric Membrane Dressing for the Treatment of Chronic Diabetic Foot Ulcers
     John D Blackman, Daniel Senseng, Lauretta T. Quinn · 1994 · Diabetes Care
165. Autophagy and the pancreatic beta-cell in human type 2 diabetes
     Piero Marchetti, Matilde Masini · 2009 · Autophagy
166. Diabetes Epidemiology: Guiding Clinical and Public Health Practice
     William H. Herman · 2007 · Diabetes Care
167. Age, Homocysteine, and Oxidative Stress: Relation to Hypertension and Type 2 Diabetes Mellitus
     Ligia Juliana Dominguez, Antonio Galioto, Antonella Pineo, Anna Ferlisi, Marcello Ciaccio, Ernesto Putignano, Mario Belvedere, Giuseppe Costanza, Mario Barbagallo · 2010 · Journal of the American College of Nutrition
168. IRS-1 Serine Phosphorylation and Insulin Resistance in Skeletal Muscle From Pancreas Transplant Recipients
     Karim Bouzakri, Håkan Karlsson, Henrik Vestergaard, Sten Madsbad, Erik Christiansen, Juleen Rae Zierath · 2006 · Diabetes
169. Metabolic Syndrome Model Definitions Predicting Type 2 Diabetes and Cardiovascular Disease
     Cécile M Povel, Joline W. J. Beulens, Yvonne T. van der Schouw, Martijn E.T. Dollé, Annemieke M. W. Spijkerman, W. M. Monique Verschuren, Edith J. M. Feskens, Jolanda M.A. Boer · 2012 · Diabetes Care
170. Hyperbaric oxygen and wound healing
     Ronald N. Roth, Larry D. Weiss · 1994 · Clinics in Dermatology
171. Comparative Effectiveness of Basal-BolusVersusPremix Analog Insulin on Glycemic Variability and Patient-Centered Outcomes during Insulin Intensification in Type 1 and Type 2 Diabetes: A Randomized, Controlled, Crossover Trial
     Marcia A. Testa, Jasvinder Gill, Max Su, Ralph R. Turner, Lawrence Blonde, Donald C. Simonson · 2012 · The Journal of Clinical Endocrinology & Metabolism
172. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes
     Shaneel Patel, David N Hakim, John C. Mason, Nadey Hakim · 2013 · Surgery for Obesity and Related Diseases
173. Salidroside Improves Homocysteine-Induced Endothelial Dysfunction by Reducing Oxidative Stress
     Sin Bond Leung, Huina Zhang, Chi Wai Lau · 2013 · Evidence-based Complementary and Alternative Medicine
174. Type 2 diabetes in pregnancy – An increasing problem
     Rosemary Temple, Helen R. Murphy · 2010 · Best Practice & Research Clinical Endocrinology & Metabolism
175. Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity
     Henri Honka, Jaakko Mäkinen, Jarna C. Hannukainen et al. · 2013 · Diabetologia
176. Minireview: MicroRNA Function in Pancreatic β Cells
     Sabire Özcan · 2014 · Molecular Endocrinology
177. Antioxidant status of type 2 diabetic patients in Port Harcourt, Nigeria
     EP Odum, Adetoun A. Ejilemele, VC Wakwe · 2012 · Nigerian Journal of Clinical Practice
178. Targeting type 2 diabetes: lessons from a knockout model of insulin receptor substrate 2
     Joana Moitinho Oliveira, Sandra A. Rebuffat, Rosa Gasa, Ramón Gomis · 2014 · Canadian Journal of Physiology and Pharmacology
179. Epigenetic modifiers of islet function and mass
     Dario F. De Jesus, Rohit Kulkarni · 2014 · Trends in Endocrinology and Metabolism
180. The Kallikrein-Kinin System in Diabetic Retinopathy
     Menakshi Bhat, Mylène Pouliot, Réjean Couture, Elvire Vaucher · 2014 · Springer eBooks
181. Mechanisms of the Incretin Effect in Subjects with Normal Glucose Tolerance and Patients with Type 2 Diabetes
     Andrea Mari, Jonatan Ising Bagger, Ele Ferrannini, Jens Juul Holst, Filip Krag Knop, Tina Vilsbøll · 2013 · PLoS ONE
182. Muscle-nerve involvement in autosomal dominant progressive external ophthalmoplegia with hypogonadism
     Atle Melberg, P. O. Lundberg, Karl Gösta Henriksson, Yngve Olsson, Erik V. St�lberg · 1996 · Muscle & Nerve
183. Bile acid sequestrants: more than simple resins
     Carolien Out, A. K. Groen, G. Brufau · 2012 · Current Opinion in Lipidology
184. Management of patients with hypertension and diabetes mellitus: advances in the evidence for intensive treatment
     William B. White, Louis Michael Prisant, Jackson T. Wright · 2000 · The American Journal of Medicine
185. Pharmacological Treatment of the Pathogenetic Defects in Type 2 Diabetes
     Jeppe Gram, Jan Erik Henriksen, Ellen Grodum, Henning Juhl, Tony Bill Hansen, Christian Fynbo Christiansen, Knud Bonnet Yderstræde, Hans Jørgen Gjessing, Henrik M. Hansen, Vibe Vestergaard et al. · 2010 · Diabetes Care
186. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
     Thavatchai Peerapatdit, Natchai Patchanans, Atip Likidlilid, Saiphon Poldee, Charn Sriratanasathavorn · 2006 · PubMed
187. Uncoupling and reactive oxygen species (ROS) – A double-edged sword for β-cell function? “Moderation in all things”
     Sheila Collins, Jingbo Pi, Einav Yehuda‐Shnaidman · 2012 · Best Practice & Research Clinical Endocrinology & Metabolism
188. AAEE case report #13: Diabetic amyotrophy
     Sudhansu Chokroverty · 1987 · Muscle & Nerve
189. Association of Cardiovascular Trial Registration With Positive Study Findings
     Connor A. Emdin, Ayodele Odutayo, Allan J. Hsiao, Mubeen Shakir, Sally Hopewell, Kazem Rahimi, Douglas G. Altman · 2014 · JAMA Internal Medicine
190. Glycemic Control and Prevention of Retinopathy in Japanese NIDDM Patients: A 10-year follow-up study
     Tomoko Nakagami, Reiko Kawahara, Sadao Hori · 1997 · Diabetes Care
191. Mitochondrial Hormesis in PancreaticβCells: Does Uncoupling Protein 2 Play a Role?
     Ning Li, Suzana Stojanovski, Pierre Maechler · 2012 · Oxidative Medicine and Cellular Longevity
192. Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
     James Taylor, Morgan Anderson, Jason Powell, Kendall M. Campbell · 2014 · Diabetes Metabolic Syndrome and Obesity
193. Islet amyloid and type 2 diabetes: overproduction or inadequate clearance and detoxification?
     Gupta, Dhananjay, Leahy, Jack L. · 2014 · Journal of Clinical Investigation
194. Have we reached the limits for the treatment of diabetic nephropathy?
     Reza Hajhosseiny, Kaivan Khavandi, Naheed K. Jivraj, Soudeh Mashayekhi, David J.A. Goldsmith, Rayaz Ahmed Malik · 2014 · Expert Opinion on Investigational Drugs
195. Hyperglycemia and redox status regulate RUNX2 DNA-binding and an angiogenic phenotype in endothelial cells
     Maria T. Mochin, Karen F. Underwood, Brandon Cooper, John C. McLenithan, Adam D. Pierce, Cesar Nalvarte, Jack L. Arbiser, Anna Isabella Karlsson, Alexander R. Moise, Jackob Moskovitz et al. · 2014 · Microvascular Research
196. Factors influencing plasma homocysteine levels in type 2 diabetes.
     Angelina Passaro, K. D’Elia, Pier Luigi Pareschi · 2000 · Diabetes Care
197. Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function
     Chen Wang, Xiaowen Li, Kaida Mu, Ling Li, Shihong Wang, Yunxia Zhu, Mingliang Zhang, Jiyoon Ryu, Zhifang Xie, Dongyun Shi et al. · 2013 · Diabetologia
198. Banting Memorial Lecture 2014 Technology and diabetes care: appropriate and personalized
     John C. Pickup · 2014 · Diabetic Medicine
199. Serum Vitamin C Levels in Type 2 Diabetic Nephropathy
     Kenzo Iino, Takuko Fukui, Keizo Anzai · 2005 · Diabetes Care
200. Diagnosis and Management of Type 2 Diabetes
     Steven V. Edelman, Robert R. Henry · 2001